Marshall Wace
CANO

Marshall Wace’s Cano Health, Inc. CANO Stock Holding History

Marshall Wace’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-289
Closed -$40.2K – 2826
2023
Q2 		$40.2K Buy
+289
New +$37.1K ﹤0.01% 2375
2022
Q3 		– Sell
-244
Closed -$107K – 3935
2022
Q2 		$107K Sell
244
-13,762
-98% -$7.18M ﹤0.01% 3273
2022
Q1 		$8.89M Buy
14,006
+7,364
+111% +$4.64M 0.02% 954
2021
Q4 		$5.92M Buy
+6,642
New +$6.98M 0.01% 1241
2021
Q3 		– Sell
-857
Closed -$1.04M – 3550
2021
Q2 		$1.04M Buy
+857
New +$1.16M ﹤0.01% 1786
2021
Q1 		– Sell
-2,500
Closed -$3.35M – 2961
2020
Q4 		$3.35M Hold
2,500
– – 0.02% 721
2020
Q3 		$2.6M Buy
+2,500
New +$2.61M 0.02% 735

Other funds holding CANO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Marshall Wace's CANO Position: Q3 2023 in Review

Marshall Wace sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 289 shares — an estimated $40.2K sold.

Marshall Wace first reported a position in CANO in Q3 2020 and held it in 7 quarters. The position peaked at $8.89M in Q1 2022. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

  • Marshall Wace reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 289 Cano Health, Inc. shares in Q3 2023, an estimated $40.2K.
  • Marshall Wace first reported a position in Cano Health, Inc. in Q3 2020 and held it in 7 quarters.
  • Marshall Wace's Cano Health, Inc. position peaked at $8.89M in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.